
uidelines Are Never Enough: A Commentary on "When Guidelines Are Not Enough

Hepatocellular Carcinoma Presenting As Radiculopathy
Addition of Histone Deacetylase Inhibitors in Combination Therapy
Adjuvant Chemotherapy for High-Risk Operable Breast Cancer
Integrin Inhibitors Reaching the Clinic

Chromogranin A: Is It a Useful Marker of Neuroendocrine Tumors?

Impact of a Peer-Delivered Telephone Intervention for Women Experiencing a Breast Cancer Recurrence
Cytotoxicity of Dimethylacetamide and Pharmacokinetics in Children Receiving Intravenous Busulfan

Imaging in Local Staging of Gastric Cancer: A Systematic Review